ESLA logo

Estrella Immunopharma (ESLA)

Profile

Full Name

Estrella Immunopharma, Inc.

Ticker Symbol

NASDAQ: ESLA

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

September 14, 2021

Indexes

Not included

Website

http://www.estrellabio.com

Employees

-

Key Details

Price

$0.88(-0.11%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$0.12(+55.56% YoY)

PE ratio

-

Next earnings date

Sep 26, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $0.88
    ESLA price is $0.88

    30-Day Relative Volume

    0.05
    ESLA 30-day relative volume is 0.05

    Price Performance

    Price Most recent change

    -0.11%
    ESLA price was down -0.11% on Jul 3, 2025

    Price YTD change

    -26.67%
    ESLA price is down -26.67% since January 1st

    Price 1-year change

    -23.14%
    ESLA price is down -23.14% year-on-year

    Price 3-year change

    -91.2%
    ESLA price is down -91.2% over the past 3 years

    Price Range

    Price All-time high

    $33.00
    ESLA price is currently -97.33% below its historical high of $33.00

    Price 3-year low

    $0.63
    ESLA price is currently +39.68% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $31.83M
    ESLA market capitalization is $31.83 million

    Market cap 3-year change

    -
    ESLA market capitalization 3-year change is unknown

    Market cap All-time high

    $122.15M
    ESLA market capitalization is currently -73.94% below its historical high of $122.15 million

    Market cap sector rank

    30.02%
    ESLA market capitalization is higher than 30.02% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    -0.34%
    ESLA shares outstanding is down -0.34% year-on-year

    Shares Outstanding 3-Year Change

    -
    ESLA shares outstanding 3-year change is unknown

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.38
    ESLA beta is 0.38

    200-day SMA

    $1.02
    ESLA price is currently -13.80% below its 200-day simple moving average

    50-day SMA

    $1.00
    ESLA price is currently -11.80% below its 50-day simple moving average

    RSI

    44.20
    ESLA 14-day relative strength index is 44.20

    Volume

    0.05
    ESLA 30-day relative volume is 0.05

    ATR

    $0.10
    ESLA average true range is $0.10

    10-day Historical Volatility

    98.89%
    ESLA 10-day historical volatility is 98.89%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    -
    ESLA annual revenue value is unknown

    Revenue Analysts estimate

    -
    ESLA annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    -
    ESLA annual revenue 1-year change is unknown

    Revenue Sector rank

    -
    ESLA annual revenue is unknown

    EPS

    EPS

    -$0.12
    ESLA annual earnings per share is -$0.12

    EPS Analysts estimate

    -$0.46
    ESLA annual earnings per share is currently -73.91% lower than the consensus analysts' forecast

    EPS 1-year change

    +55.56%
    ESLA annual earnings per share is up +55.56% year-on-year

    EPS Sector rank

    78.73%
    ESLA annual earnings per share is higher than 78.73% of companies in Healthcare sector

    Profit

    Gross profit

    -
    ESLA annual gross profit value is unknown

    Gross margin

    -
    ESLA annual gross profit margin value is unknown

    Operating profit

    -$4.43M
    ESLA annual operating income is -$4.43 million

    Operating margin

    -
    ESLA annual operating profit margin value is unknown

    Net income

    -$4.43M
    ESLA annual net profit is -$4.43 million

    Net margin

    -
    ESLA annual net profit margin value is unknown

    Expenses

    Total expenses

    $4.43M
    ESLA annual total expenses is $4.43 million

    Operating expenses

    $4.43M
    ESLA annual total operating expenses is $4.43 million

    Cost of goods sold

    -
    ESLA annual cost of goods sold value is unknown

    Selling, general & administrative expenses

    $1.57M
    ESLA annual SGA is $1.57 million

    Depreciation and amortization

    -
    ESLA annual depreciation & amortization value is unknown

    Interest expense

    -
    ESLA annual interest expense value is unknown

    Income tax

    $100.00
    ESLA annual income tax is $100.00

    EBIT & EBITDA

    EBIT

    -$4.43M
    ESLA annual earnings before interest & taxes is -$4.43 million

    EBITDA

    -$4.43M
    ESLA annual EBITDA is -$4.43 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $3.14M
    ESLA annual total assets is $3.14 million

    Non current assets

    $1.50M
    ESLA annual long term assets is $1.50 million

    Current assets

    $1.64M
    ESLA annual total current assets is $1.64 million

    Cash and cash equivalents

    $916.90K
    ESLA annual cash & cash equivalents is $916.90 thousand

    Accounts receivable

    -
    ESLA annual accounts receivable value is unknown

    Inventory

    -
    ESLA annual inventory value is unknown

    Liabilities

    Total liabilities

    $3.00M
    ESLA annual total liabilities is $3.00 million

    Long term liabilities

    $0.00
    ESLA annual total long term liabilities is $0.00

    Current liabilities

    $3.00M
    ESLA annual total current liabilities is $3.00 million

    Accounts payable

    $4400.00
    ESLA annual accounts payable is $4400.00

    Debt

    Total debt

    $0.00
    ESLA annual total debt is $0.00

    Total debt 1-year change

    0%
    ESLA {parameterFullLabel} has remained unchanged year-on-year

    Long term debt

    -
    ESLA annual long term debt value is unknown

    Short term debt

    -
    ESLA annual short term debt value is unknown

    Equity & Capital

    Shareholders equity

    $143.70K
    ESLA annual stockholders equity is $143.70 thousand

    Book value

    $143.70K
    ESLA annual book value is $143.70 thousand

    Retained earnings

    -$23.93M
    ESLA annual retained earnings is -$23.93 million

    Working capital

    -$1.36M
    ESLA annual working capital is -$1.36 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$3.11M
    ESLA annual cash flow from operations is -$3.11 million

    Cash from operations 1-year change

    +80.62%
    ESLA annual cash flow from operations is up +80.62% year-on-year

    Cash from investing

    $0.00
    ESLA annual cash flow from investing activities is $0.00

    Cash from investing 1-year change

    -100%
    ESLA annual cash flow from investing activities is down -100% year-on-year

    Cash from financing

    -$135.00K
    ESLA annual cash flow from financing activities is -$135.00 thousand

    Cash from financing 1-year change

    -101.06%
    ESLA annual cash flow from financing activities is down -101.06% year-on-year

    CAPEX

    CAPEX

    -
    ESLA annual capital expenditures value is unknown

    CAPEX 1-year change

    -
    ESLA annual capital expenditures 1-year change is unknown

    Free Cash Flow

    Free cash flow

    -$3.11M
    ESLA annual free cash flow is -$3.11 million

    Free cash flow 1-year change

    +80.62%
    ESLA annual free cash flow is up +80.62% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    ESLA annual gross profit margin value is unknown

    Operating margin

    -
    ESLA annual operating profit margin value is unknown

    Net margin

    -
    ESLA annual net profit margin value is unknown

    ROA & ROE

    ROA

    -140.95%
    ESLA annual return on assets is -140.95%

    ROE

    -3080.72%
    ESLA annual return on equity is -3080.72%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    ESLA price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    ESLA price to earnings ratio is unknown

    PB Ratio

    PB ratio

    -17.38
    ESLA price to book ratio is -17.38

    PB ratio Sector rank

    2.63%
    ESLA price to book ratio is higher than 2.63% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    ESLA price to sales ratio value is unknown

    PS ratio Sector rank

    -
    ESLA price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $31.40M
    ESLA enterprise value is $31.40 million

    Enterprise value Sector rank

    33.09%
    ESLA enterprise value is higher than 33.09% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -3.33
    ESLA EV/EBITDA is -3.33

    EV/EBITDA Sector rank

    29.96%
    ESLA EV/EBITDA is higher than 29.96% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    0.55
    ESLA annual current ratio is 0.55

    Quick ratio

    -
    ESLA annual quick ratio value is unknown

    Leverage

    Debt to equity

    0.00
    ESLA annual debt to equity ratio is 0.00

    Interest coverage ratio

    -
    ESLA annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    ESLA piotroski f-score value is unknown

    Altman Z-Score

    -
    ESLA altman z-score value is unknown

    Analyst ratings

    Recent major analysts updates

    Jun 3, 25 D. Boral Capital
    Buy
    May 29, 25 D. Boral Capital
    Buy
    Feb 21, 25 D. Boral Capital
    Buy
    Feb 18, 25 D. Boral Capital
    Buy

    Institutional Ownership

    Screeners with ESLA included

    Stocks cheaper than 1 dollar
    US stocks
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    • What is the ticker symbol for Estrella Immunopharma?
    • Does Estrella Immunopharma pay dividends?
    • What sector is Estrella Immunopharma in?
    • What industry is Estrella Immunopharma in?
    • What country is Estrella Immunopharma based in?
    • When did Estrella Immunopharma go public?
    • Is Estrella Immunopharma in the S&P 500?
    • Is Estrella Immunopharma in the NASDAQ 100?
    • Is Estrella Immunopharma in the Dow Jones?
    • When was Estrella Immunopharma's last earnings report?
    • When does Estrella Immunopharma report earnings?

    What is the ticker symbol for Estrella Immunopharma?

    The ticker symbol for Estrella Immunopharma is NASDAQ:ESLA

    Does Estrella Immunopharma pay dividends?

    No, Estrella Immunopharma does not pay dividends

    What sector is Estrella Immunopharma in?

    Estrella Immunopharma is in the Healthcare sector

    What industry is Estrella Immunopharma in?

    Estrella Immunopharma is in the Biotechnology industry

    What country is Estrella Immunopharma based in?

    Estrella Immunopharma is headquartered in United States

    When did Estrella Immunopharma go public?

    Estrella Immunopharma's initial public offering (IPO) was on September 14, 2021

    Is Estrella Immunopharma in the S&P 500?

    No, Estrella Immunopharma is not included in the S&P 500 index

    Is Estrella Immunopharma in the NASDAQ 100?

    No, Estrella Immunopharma is not included in the NASDAQ 100 index

    Is Estrella Immunopharma in the Dow Jones?

    No, Estrella Immunopharma is not included in the Dow Jones index

    When was Estrella Immunopharma's last earnings report?

    Estrella Immunopharma's most recent earnings report was on May 14, 2025

    When does Estrella Immunopharma report earnings?

    The next expected earnings date for Estrella Immunopharma is September 26, 2025
    On this page